Skip to main content

Sleep Disordered Breathing

1
Pipeline Programs
9
Companies
9
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
1
Prototype nasal dilator stripPhase 2
Philips
PhilipsNetherlands - Amsterdam
3 programs
BiPAP S/TN/A1 trial
BiPAP auto AdvancedN/A1 trial
Respironics BiPAP autoSV2N/A1 trial
Active Trials
NCT01241604Terminated11Est. Jul 2009
NCT01626989Completed44Est. Jun 2012
NCT00720213Completed44Est. Jul 2009
Medtronic
MedtronicNJ - Phillipsburg
2 programs
Oxygen MonitoringN/A1 trial
PAPN/A1 trial
Active Trials
NCT01082575Completed100Est. Aug 2010
NCT02727192Completed109Est. Sep 2020
Boston Scientific
Boston ScientificCA - Valencia
1 program
CRT ImplantationN/A1 trial
Active Trials
NCT02203383Suspended40Est. Oct 2017
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Dual-axis inclinometer attached to the subject's forehead with tapeN/A1 trial
Active Trials
NCT04086407Completed8Est. Nov 2017
ResMed
ResMedSAN DIEGO, CA
1 program
PAPN/A
Rhine Pharma
Rhine PharmaGermany - Heidelberg
1 program
Sleep-Disordered Breathing in Patients With Severe Valvular Regurgitation Undergoing Clip ProcedureN/A1 trial
Active Trials
NCT03813511Completed100Est. Jul 2022
GSK
GSKLONDON, United Kingdom
1 program
Prototype nasal dilator stripPHASE_21 trial
Active Trials
NCT03105297Completed91Est. Aug 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKPrototype nasal dilator strip
Rhine PharmaSleep-Disordered Breathing in Patients With Severe Valvular Regurgitation Undergoing Clip Procedure
Allergy TherapeuticsDual-axis inclinometer attached to the subject's forehead with tape
MedtronicPAP
Boston ScientificCRT Implantation
PhilipsBiPAP auto Advanced
MedtronicOxygen Monitoring
PhilipsBiPAP S/T
PhilipsRespironics BiPAP autoSV2

Clinical Trials (9)

Total enrollment: 547 patients across 9 trials

NCT03105297GSKPrototype nasal dilator strip

To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.

Start: Sep 2009Est. completion: Aug 201091 patients
Phase 2Completed
NCT03813511Rhine PharmaSleep-Disordered Breathing in Patients With Severe Valvular Regurgitation Undergoing Clip Procedure

Sleep-Disordered Breathing in Patients With Severe Valvular Regurgitation Undergoing Clip Procedure

Start: Dec 2018Est. completion: Jul 2022100 patients
N/ACompleted
NCT04086407Allergy TherapeuticsDual-axis inclinometer attached to the subject's forehead with tape

Apnea Hypopnea Index Severity Versus Head Position During Sleep

Start: Nov 2016Est. completion: Nov 20178 patients
N/ACompleted

Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation

Start: Jan 2016Est. completion: Sep 2020109 patients
N/ACompleted

The Effect of CRT on the Hypercapnic Ventilatory Response

Start: Jun 2014Est. completion: Oct 201740 patients
N/ASuspended
NCT01626989PhilipsBiPAP auto Advanced

Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders

Start: Jun 2010Est. completion: Jun 201244 patients
N/ACompleted
NCT01082575MedtronicOxygen Monitoring

Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor

Start: Feb 2010Est. completion: Aug 2010100 patients
N/ACompleted

Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device

Start: Jan 2009Est. completion: Jul 200911 patients
N/ATerminated
NCT00720213PhilipsRespironics BiPAP autoSV2

Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device

Start: Aug 2008Est. completion: Jul 200944 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.